期刊
ACS CHEMICAL BIOLOGY
卷 16, 期 11, 页码 2612-2622出版社
AMER CHEMICAL SOC
DOI: 10.1021/acschembio.1c00649
关键词
-
资金
- National Science Foundation [NSF-1518265, NSF-2054824]
- National Institutes of Health [5R01GM131168-02, R01GM130746, R01GM133967]
The study presents a novel strategy named dual encoding and labeling (DEAL) for site-specific modification of proteins in vivo, enabling detailed investigation of protein function inside cells. This approach allows for multiple labeling reactions to occur simultaneously within a single protein, expanding the possibilities for protein engineering and characterization.
The ability to site-specifically modify proteins at multiple sites in vivo will enable the study of protein function in its native environment with unprecedented levels of detail. Here, we present a versatile two-step strategy to meet this goal involving site-specific encoding of two distinct noncanonical amino acids bearing bioorthogonal handles into proteins in vivo followed by mutually orthogonal labeling. This general approach, that we call dual encoding and labeling (DEAL), allowed us to efficiently encode tetrazine- and azide-bearing amino acids into a protein and demonstrate for the first time that the bioorthogonal labeling reactions with strained alkene and alkyne labels can function simultaneously and intracellularly with high yields when site-specifically encoded in a single protein. Using our DEAL system, we were able to perform topologically defined protein-protein cross-linking, intramolecular stapling, and site-specific installation of fluorophores all inside living Escherichia coli cells, as well as study the DNA-binding properties of yeast Replication Protein A in vitro. By enabling the efficient dual modification of proteins in vivo, this DEAL approach provides a tool for the characterization and engineering of proteins in vivo.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据